NIVA KHAN: Open Payments
NPI 1063455475 · NEWPORT, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$534 in 30 payments from 13 companies in 2025. Trend: 2023 $1,570 · 2024 $1,244 · 2025 $534
Food & beverage: $534
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $184 |
| GlaxoSmithKline, LLC. | 5 | $92 |
| Novo Nordisk Inc | 2 | $41 |
| PFIZER INC. | 2 | $37 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| Astellas Pharma US Inc | 1 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| SHIELD THERAPEUTICS INC | 1 | $18 |
Products named: QULIPTA, VRAYLAR, TRELEGY ELLIPTA, ELIQUIS, Kerendia, JARDIANCE, Wegovy, Veozah.
Industry payments across KY — which companies pay providers there.
